Biohaven Ltd.

BHVN · NYSE

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

–

Growth

Health

Risk

–

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders11.2%

Institutions96.7%

Public / Other

	You	Peer avg
P/E	–	3.8
Revenue Growth	–	+3178.2%
ROE	-799.5%	-295.1%

Income Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	–	–	–	–	$462.51M	$63.63M
The direct costs of producing what was sold — raw materials, manufacturing, direct labor.	–	–	–	–	$91.66M	$17.69M
Revenue left after subtracting the direct cost of producing goods or services — how efficiently the core business converts sales into profit before overhead.	–	–	–	–	$370.85M	$45.93M
Gross profit as a percentage of revenue.	–	–	–	–	80.2%	72.2%
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	-$745.38M	-$885.11M	-$436.05M	-$567.93M	-$704.04M	-$645.39M
Operating income as a percentage of revenue.	–	–	–	–	-152.2%	-1014.3%
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$738.82M	-$846.42M	-$408.17M	-$570.28M	-$1.81M	-$1.82M
Net income divided by the number of shares outstanding — profit attributable to each share.	$-6.86	$-9.28	$-5.73	$-12.75	$-13.09	$-13.06
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$-6.86	$-9.28	$-5.73	$-12.75	$-13.09	–

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$229.96M	$99.13M	$248.40M	$204.88M	$171.94M	$132.15M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$451.45M	$615.11M	$513.21M	$661.78M	$1.08B	$686.98M
Everything the company owes — debt, unpaid bills, and other obligations.	$399.38M	$191.67M	$85.24M	$123.01M	$1.76B	$1.02B
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$52.07M	$423.44M	$427.98M	$538.77M	-$739.38M	-$390.37M

Cash Flow Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-$609.44M	-$582.45M	-$331.73M	-$297.69M	-$831.10M	-$702.88M
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$715000	$4.05M	$3.05M	$6.07M	$1.72M	$2.37M
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	-$610.15M	-$586.50M	-$334.77M	-$303.76M	-$832.82M	-$705.25M

Biohaven Ltd.

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Peer Comparison

Income Statement

Balance Sheet

Cash Flow Statement